Medical Cannabis Briefer: A European Perspective
Copenhagen, January 9, 2017
Launching today, Gemstone Capital is a highly specialized Corporate Finance advisor, uniquely positioned to serve clients in value adding tech transactions and with a particular focus upon micro-cap IPO’s.
After more than 12 months of preparation, we are proud to announce the formal launch of Gemstone Capital. We focus upon micro-cap IPOs as this is a frequent need of high potential companies in pursuit of wider market leadership. We also advise tech-companies on strategic M&A (buy and sell side) and provide access to investors and active co-ownership in tech related companies. Our edge is a unique combination of business and transaction skills. We are already “in business”, with our latest transaction, the IPO of Danish ExpreS2ion Biotechnologies on Nasdaq First North in Stockholm. More clients are signed and underway. We are senior executives from industry with an ability to rapidly develop a strategic understanding of our clients markets and – at the same time – we know how to execute the transactions required.
For more information, please contact one of the founding partners: Søren Jonas Bruun on +45 40561109 or Peter Max on +45 24242600.
Related posts
